GeneFormatics and Bristol-Myers collaborate

GeneFormatics (San Diego, Calif.) and BMY will use GeneFormatics' Fuzzy Functional Form (FFF) technology to identify therapeutic targets based on gene sequences of interest. FFF allows for the creatio...